Russell Viper Venom: A Journey from the Bedside to the Bench and Back to the Bedside

Abstract

Russell Viper Venom (RVV) is widely used as a diagnostic test for antiphospholipid syndrome (APS). But the history of how this venom came to be discovered is well known. Dr Patrick Russell is responsible for the identification of the venom during his work on snake bites in India while Dr Robert Macfarlane used it to staunch bleeding in persons with haemophilia. The ability to directly activate factor X led RVV to the laboratory diagnosis of APS. More recently, it has come back to clinical world with a potential for an engineered factor X activator from RVV to be used in the treatment of haemophilia.

Keywords

Russel Viper Venom - snake bite casualties - hemophilia

Publication History

Article published online:
28 July 2023

• References

• 1 Hawgood BJ. The life and viper of Dr Patrick Russell MD FRS (1727-1805): physician and naturalist. Toxicon 1994; 32 (11) 1295-1304
• 2 Hawgood BJ. Rosemary Biggs MD FRCP (1912-2001) and Katharine Dormandy MD FRCP (1926-78): from laboratory to treatment and care of people with haemophilia. J Med Biogr 2013; 21 (01) 41-48
• 3 Hawgood BJ. Alexander Russell (1715-1768) and Patrick Russell (1727-1805): physicians and natural historians of Aleppo. J Med Biogr 2001; 9 (01) 1-6
• 4 Wellcome Collection. Accessed June 6, 2023 at: https://wellcomecollection.org/works/ytu8w5nq
• 5 Chakrabarti P. “Neither of meate nor drinke, but what the Doctor alloweth”: medicine amidst war and commerce in eighteenth-century Madras. Bull Hist Med 2006; 80 (01) 1-38
• 6 Raman R, Raman A, Ram Manohar P. The arsenic and mercury-containing Tanjore pills used in treating snake bites in the 18th century Madras Presidency. Curr Sci 2014; 106: 1759-1763
• 7 An account of Indian serpents, collected on the coast of Coromandel: containing descriptions and drawings of each species, together with experiments and remarks on their several poisons. Accessed June 7, 2023 at: https://www.biodiversitylibrary.org/bibliography/114003
• 8 Owen Jr CA. Historical account of tests of hemostasis. Am J Clin Pathol 1990; 93 (4, Suppl 1): S3-S8
• 9 Douglas S. Coagulation history, Oxford 1951-53. Br J Haematol 1999; 107 (01) 22-32
• 10 Mellanby J. The coagulation of blood. J Physiol 1908; 38 (01) 28-112
• 11 Martin CJ. On some effects upon the blood produced by the injection of the venom of the Australian Black Snake (Pseudechis Porphyriacus). J Physiol 1893; 15 (04) 380-400
• 12 Mellanby J. The coagulation of blood: part II. The actions of snake venoms, peptone and leech extract. J Physiol 1909; 38 (06) 441-503
• 13 Eagle H. The coagulation of blood by snake venoms and its physiologic significance. J Exp Med 1937; 65 (05) 613-639
• 14 MacFarlane RG. An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 1964; 202: 498-499
• 15 Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145 (3638): 1310-1312
• 16 Macfarlane RG. Russell's viper venom, 1934-64. Br J Haematol 1967; 13 (04) 437-451
• 17 Macfarlane RG, Barnett B. The haemostatic possibilities of snake-venom. Lancet 1934; 224: 985-987
• 18 Directions for using 'Stypven' Russell Viper Venom (not for injection). Accessed June 6, 2023 at: https://wellcomecollection.org/works/urrqg9by
• 19 MacFarlane RG, Ash BJ. The activation and consumption of factor X in recalcified plasma. The effect of added factor VIII and Russell's Viper Venom. Br J Haematol 1964; 10: 217-224
• 20 Macfarlane RG, Trevan JW, Attwood AM. Participation of a fat soluble substance in coagulation of the blood. J Physiol 1941; 99: 7
• 21 Macfarlane RG. Proceedings of the Association of Clinical Biochemists. 1964; 3: 61-137
• 22 Quick AJ. The prothrombin in hemophilia and in obstructive jaundice. J Biol Chem 1935; 109: 83
• 23 MacFarlane RG. The coagulant action of Russell's viper venom; the use of antivenom in defining its reaction with a serum factor. Br J Haematol 1961; 7: 496-511
• 24 Esnouf MP, Williams WJ. The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell's-viper venom. Biochem J 1962; 84 (01) 62-71
• 25 Shapiro SS, Thiagarajan P, De Marco L. Mechanism of action of the lupus anticoagulant. Ann N Y Acad Sci 1981; 370: 359-365
• 26 Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48 (04) 499-509
• 27 Triplett DA, Brandt JT, Maas RL. The laboratory heterogeneity of lupus anticoagulants. Arch Pathol Lab Med 1985; 109 (10) 946-951
• 28 Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68 (04) 869-874
• 29 Devreese KMJ, de Groot PG, de Laat B. et al. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation. J Thromb Haemost 2020; 18 (11) 2828-2839
• 30 Liu W, Xue F, Fu R. et al. Preclinical studies of a factor X activator and a phase 1 trial for hemophilia patients with inhibitors. J Thromb Haemost 2023; 21 (06) 1453-1465